Condition: Non-Alcoholic Fatty Liver Disease · Non-alcoholic Steatohepatitis · Alcoholic Liver Disease · Sponsor: Manchester University NHS Foundation Trust
This is an observational study that will explore the hypothesis that by combining data from patients with liver disease with novel blood biomarkers, single nucleotide polymorphism (SNP) analysis and faecal microbiome analysis. The Investigators will improve diagnosis of liver fibrosis compared to the current available diagnostic tools.
This description comes directly from the study's public registry record.
Varinder Athwal · 0161 291 5354 · Varinder.athwal@manchester.ac.uk
Always discuss trial participation with your own doctor first.
| Manchester University NHS Foundation Trust | Manchester, Greater Manchester, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04666402